Scott Ribich
Impact in
-
- Thyroid Disorders and Treatments
- Growth Hormone and Insulin-like Growth Factors
- Molecular Biology top 5%
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
- RNA modifications and cancer
- Chromatin Remodeling and Cancer
Papers in
-
- Cancer-related gene regulation 13
- Chromatin Remodeling and Cancer 9
- Epigenetics and DNA Methylation 7
- RNA modifications and cancer 7
-
- Cancer Mechanisms and Therapy 4
- Co-authors
- Antônio C. Bianco (6 shared papers)Brian W. Kim (3 shared papers)Stephen A. Huang (2 shared papers)Anikó Zeöld (1 shared paper)Ann Marie Zavacki (1 shared paper)Warner S. Simonides (1 shared paper)Balázs Gereben (1 shared paper)Pamela J. McLean (2 shared papers)
- Journals
- Molecular Cancer Therapeutics (6 papers)Cancer Research (5 papers)ACS Medicinal Chemistry Letters (2 papers)Endocrinology (2 papers)Endocrine Reviews (2 papers)
- Partner nations
- United StatesFranceItaly
In The Last Decade
Scott Ribich
35 papers receiving 2.9k citations
Scott Ribich's Hit Papers
Peers
Comparison fields: 5 of 110
- Endocrinology, Diabetes and Metabolism 539
- Molecular Biology 1.7k
- Oncology 556
- Neurology 277
- Cancer Research 260
Countries citing papers authored by Scott Ribich
This map shows the geographic impact of Scott Ribich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Ribich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Ribich more than expected).
Fields of papers citing papers by Scott Ribich
This network shows the impact of papers produced by Scott Ribich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Ribich. The network helps show where Scott Ribich may publish in the future.
Co-authors
The 25 scholars most cited alongside Scott Ribich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cellular and Molecular Basis of Deiodinase-Regulated Thyroid Hormone Signaling1 Hit paper breakdown → | 2008 | 643 |
| 2 | Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study Hit paper breakdown → | 2018 | 451 |
| 3 | 2017 | 347 | |
| 4 | 2002 | 244 | |
| 5 | 2000 | 211 | |
| 6 | 2017 | 127 | |
| 7 | 2018 | 108 | |
| 8 | 2015 | 95 | |
| 9 | 2006 | 94 | |
| 10 | 2010 | 85 | |
| 11 | 2008 | 63 | |
| 12 | 2016 | 58 | |
| 13 | 2000 | 54 | |
| 14 | 2017 | 52 | |
| 15 | 2017 | 43 | |
| 16 | 2011 | 39 | |
| 17 | 2019 | 36 | |
| 18 | 2017 | 35 | |
| 19 | 2015 | 32 | |
| 20 | 2009 | 28 |
About Scott Ribich
Scott Ribich is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Physiology, Oncology and Cancer Research, having authored 37 papers that have together received 2.9k indexed citations. Recurring topics across this work include Cancer-related gene regulation (13 papers), Chromatin Remodeling and Cancer (9 papers), Epigenetics and DNA Methylation (7 papers), RNA modifications and cancer (7 papers), Adipose Tissue and Metabolism (5 papers), Cancer Mechanisms and Therapy (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Advanced Breast Cancer Therapies (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (539 citations), Molecular Biology (1.7k citations), Oncology (556 citations), Neurology (277 citations) and Cancer Research (260 citations). Scott Ribich has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Antônio C. Bianco, Brian W. Kim, Stephen A. Huang, Anikó Zeöld, Ann Marie Zavacki, Warner S. Simonides, Balázs Gereben, Pamela J. McLean, Bradley T. Hyman and Robert A. Copeland. Their work appears in journals such as Molecular Cancer Therapeutics, Cancer Research, ACS Medicinal Chemistry Letters, Endocrinology and Endocrine Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.